Jean-Pierre Bassand
Overview
Explore the profile of Jean-Pierre Bassand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
8236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Himmelreich J, Virdone S, Camm A, Pieper K, Harskamp R, Verheugt F, et al.
Open Heart
. 2025 Jan;
12(1.
PMID: 39832940
Aims: This study aimed to determine the robustness, reproducibility and representativeness of the landmark Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (AF) (ARISTOTLE) and Rivaroxaban...
2.
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry
Goldhaber S, Bassand J, Camm A, Virdone S, Pieper K, Cools F, et al.
Am J Med
. 2023 Nov;
137(2):128-136.e13.
PMID: 37918777
Background: Oral anticoagulants (OAC) are underutilized in older patients with atrial fibrillation, despite proven clinical benefits. Our objective was to investigate baseline characteristics, treatment patterns, and impact of anticoagulation upon...
3.
Bassand J, Virdone S, Camm A, Fox K, Goldhaber S, Goto S, et al.
Diabetes Obes Metab
. 2023 Jul;
25(10):3040-3053.
PMID: 37435777
Aims: This study aims to describe both management and prognosis of patients with diabetes mellitus (DM) and newly diagnosed atrial fibrillation (AF), overall as well as by antidiabetic treatment, and...
4.
Camm A, Steffel J, Virdone S, Bassand J, Fox K, Goldhaber S, et al.
Eur Heart J Open
. 2023 Jun;
3(3):oead051.
PMID: 37293139
Aims: This study aimed to identify relationships in recently diagnosed atrial fibrillation (AF) patients with respect to anticoagulation status, use of guideline-directed medical therapy (GDMT) for comorbid cardiovascular conditions (co-GDMT),...
5.
Apenteng P, Virdone S, Camm J, Fox K, Bassand J, Turpie A, et al.
Open Heart
. 2023 May;
10(1).
PMID: 37169491
Objective: There is a substantial incidence of stroke in patients with atrial fibrillation (AF) not receiving anticoagulation. The reasons for not receiving anticoagulation are generally attributed to clinician's choice, however,...
6.
Mantovani L, Cozzolino P, Ferrara P, Virdone S, Camm A, Verheugt F, et al.
Healthcare (Basel)
. 2023 Mar;
11(5).
PMID: 36900643
The management of atrial fibrillation (AF), the most common sustained arrhythmia, impacts healthcare resource utilization (HCRU). This study aims to estimate global resource use in AF patients, using the GARFIELD-AF...
7.
Fox K, Virdone S, Bassand J, Camm A, Goto S, Goldhaber S, et al.
BMJ Open
. 2022 Jan;
12(1):e049933.
PMID: 34996784
Objective: In patients with newly diagnosed atrial fibrillation (AF), do baseline risk factors and stroke prevention strategies account for the geographically diverse outcomes. Design: Global Anticoagulant Registry in the FIELD-Atrial...
8.
Cools F, Johnson D, Camm A, Bassand J, Verheugt F, Yang S, et al.
J Thromb Haemost
. 2021 Jun;
19(9):2322-2334.
PMID: 34060704
Background: Oral anticoagulation (OAC) in atrial fibrillation (AF) reduces the risk of stroke/systemic embolism (SE). The impact of OAC discontinuation is less well documented. Objective: Investigate outcomes of patients prospectively...
9.
Fox K, Virdone S, Pieper K, Bassand J, Camm A, Fitzmaurice D, et al.
Eur Heart J Qual Care Clin Outcomes
. 2021 Apr;
8(2):214-227.
PMID: 33892489
Aims: To determine whether the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) integrated risk tool predicts mortality, non-haemorrhagic stroke/systemic embolism, and major bleeding for up to 2 years after...
10.
Pope M, Atar D, Svilaas A, Hole T, Nielsen J, Hintze U, et al.
Ann Med
. 2021 Apr;
53(1):485-494.
PMID: 33818226
Aims: The objective was to evaluate the clinical characteristics, management and two-year outcomes of patients with newly diagnosed non-valvular atrial fibrillation at risk for stroke in Nordic countries. Methods: We...